NCT03546400View on ClinicalTrials.gov

Safety, Tolerability and PK Study of Methylphenidate HCl ERCT in 4-5 Year Old Children With ADHD.

PHASE4WithdrawnINTERVENTIONAL
0
Timeline

Start Date

September 25, 2018

Primary Completion Date

December 3, 2020

Study Completion Date

December 3, 2020

Conditions
Attention Deficit Hyperactivity Disorder (ADHD)
Interventions
DRUG

methylphenidate HCl ERCT

methylphenidate HCl ERCT

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT03546400 - Safety, Tolerability and PK Study of Methylphenidate HCl ERCT in 4-5 Year Old Children With ADHD. | Biotech Hunter | Biotech Hunter